Issues, indications, and controversies regarding intratympanic steroid perfusion.
OBJECTIVE
Office-based intratympanic inner ear steroid perfusion (ITPs) treatment for Ménière's disease, autoimmune inner ear disease, and sudden sensorineural hearing loss has been expanding over the past 10-15 years, yet remains controversial. The purpose of this review is to examine the current literature of basic science and human studies of ITPs treatment.


RESULTS
Animal studies exist regarding the delivery, distribution, biochemical, and microbiological changes in the inner ear post ITPs. However, few clinical studies exist on ITPs treatment in sudden sensorineural hearing loss and even less in treating Ménière's disease. There are no consistent studies regarding drug delivery methods, type, and concentration of steroids. Moreover, there are no studies comparing ITPs results to the natural history of Ménière's disease.


CONCLUSIONS
ITPs has impacted otology and neurotology practice due to increased utilization. A sound understanding of the basic science and clinical studies is needed to establish long-term efficacy of ITPs in controlling hearing loss in Ménière's disease by comparison to its natural history, as well as, potential application to other disorders.
Hamid
Mohamed
M
The Cleveland Hearing & Balance Center, Cleveland, Ohio 44122, USA. hamidma@ClevelandHearingBalance.com
Trune
Dennis
D
D000818:Animals; D015331:Cohort Studies; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D016503:Drug Delivery Systems; D005260:Female; D006319:Hearing Loss, Sensorineural / Q000175:diagnosis / Q000188:drug therapy*; D003639:Hearing Loss, Sudden / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D036502:Infusions, Intralesional; D008297:Male; D008575:Meniere Disease / Q000175:diagnosis / Q000188:drug therapy*; D011379:Prognosis; D018570:Risk Assessment; D013256:Steroids / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome; D014432:Tympanic Membrane / Q000187:drug effects*
D013256:Steroids
Curr Opin Otolaryngol Head Neck Surg. 2006 Oct;14(5):329-31
16974146
HNO. 2008 May;56(5):524-9
18409074
J Laryngol Otol. 2005 Jan;119(1):2-7
15807953
Hear Res. 2006 Dec;222(1-2):70-8
17070001
Otol Neurotol. 2008 Jun;29(4):453-60
18401285
Otolaryngol Head Neck Surg. 2007 Nov;137(5):747-52
17967639
Laryngoscope. 2008 Feb;118(2):279-82
17989574
Otolaryngol Head Neck Surg. 2007 Jul;137(1):74-8
17599569
Laryngoscope. 2007 Jul;117(7):1209-15
17603319
Laryngoscope. 2007 Apr;117(4):695-8
17415141
Neurosci Res. 2007 Jul;58(3):250-4
17462767
Otolaryngol Head Neck Surg. 2006 Jun;134(6):940-5
16730534
Laryngoscope. 2007 Mar;117(3):415-20
17279053
In Vivo. 2007 Nov-Dec;21(6):1043-7
18210753
Cell Tissue Res. 2007 Jun;328(3):453-60
17318586
Am J Otol. 1998 Mar;19(2):196-201
9520056
Acta Otolaryngol. 2007 Jul;127(7):676-81
17573561
Ann Otol Rhinol Laryngol. 2007 Apr;116(4):253-6
17491522
Acta Otolaryngol. 2007 Nov;127(11):1162-7
17851886
Otol Neurotol. 2002 May;23(3):316-22
11981388
Acta Otolaryngol. 2005 Jan;125(1):9-15
15799567
Eur Arch Otorhinolaryngol. 2005 Feb;262(2):131-4
15747106
Otol Neurotol. 2008 Jan;29(1):33-8
18199956
Laryngoscope. 2008 Jun;118(6):1057-62
18401276
Laryngoscope. 1999 Jul;109(7 Pt 2):1-17
10399889
Acta Otolaryngol. 2007 Oct;127(10):1012-7
17851934
Audiol Neurootol. 2006;11(6):357-65
16988499
Acta Otolaryngol Suppl. 2004 Aug;(553):13-8
15277029
Otol Neurotol. 2005 Sep;26(5):890-5
16151334
Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1751-6
18218777
Acta Otolaryngol. 2008 Feb;128(2):128-31
17851916
Otol Neurotol. 2008 Apr;29(3):401-6
18277312
Arch Otolaryngol Head Neck Surg. 2007 Jun;133(6):582-6
17576909
Otolaryngol Head Neck Surg. 2007 Aug;137(2):332-7
17666266
Curr Opin Otolaryngol Head Neck Surg. 2006 Oct;14(5):332-6
16974147
ORL J Otorhinolaryngol Relat Spec. 2006;68(6):386-92
17065834
Chin Med J (Engl). 2007 Dec 20;120(24):2284-9
18167219
Hear Res. 2007 Apr;226(1-2):114-25
17184943
Neurol Res. 2003 Dec;25(8):865-70
14669532
Clin Otolaryngol Allied Sci. 1998 Jun;23(3):263-4
9669078
Hear Res. 2007 Apr;226(1-2):209-17
17098384
Otol Neurotol. 2006 Jun;27(4):564-9
16691147
Laryngoscope. 2007 Jan;117(1):3-15
17202923
Acta Otorrinolaringol Esp. 2005 Feb;56(2):74-7
15782646
ORL J Otorhinolaryngol Relat Spec. 2008;70(1):21-6; discussion 26-7
18235202
Auris Nasus Larynx. 1986;13(2):79-89
3813983
Otolaryngol Clin North Am. 1996 Apr;29(2):353-8
8860933
Laryngoscope. 2007 Jul;117(7):1191-8
17603318
Otolaryngol Clin North Am. 2004 Oct;37(5):1035-51
15474109
Laryngorhinootologie. 2006 Jan;85(1):32-7
16444653
Otolaryngol Head Neck Surg. 2005 Aug;133(2):285-94
16087029
Otol Neurotol. 2007 Dec;28(8):1124-30
18043438
Physiol Genomics. 2006 Jan 12;24(2):114-23
16263802
Otol Neurotol. 2007 Sep;28(6):842-9
17471110
Ear Hear. 2006 Oct;27(5):457-65
16957497
Acta Otolaryngol. 2002 Sep;122(6):600-6
12403121
Otol Neurotol. 2005 Sep;26(5):878-81
16151332
Laryngoscope. 2007 Dec;117(12):2174-82
18322422
Hear Res. 2007 Oct;232(1-2):78-86
17662546
Audiol Neurootol. 2007;12(1):37-48
17119332
Laryngoscope. 2006 Apr;116(4):627-9
16585870
Hear Res. 2006 Feb;212(1-2):22-32
16307853
Neuropharmacology. 2007 May;52(6):1426-37
17449343
Eur Arch Otorhinolaryngol. 2006 Sep;263(9):791-7
16724210
J Assoc Res Otolaryngol. 2006 Jun;7(2):182-93
16718612
J Assoc Res Otolaryngol. 2007 Sep;8(3):305-28
17541769
Acta Otolaryngol. 2007 Nov;127(11):1124-31
17851919
Arch Otolaryngol Head Neck Surg. 2007 Jun;133(6):573-81
17576908